Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis.
第一作者:
M,Takata
第一单位:
Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan.
作者:
主题词
1-(5-异喹啉磺酰基)-2-甲基哌嗪(1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine);肌萎缩侧索硬化(Amyotrophic Lateral Sclerosis);动物(Animals);疾病模型, 动物(Disease Models, Animal);疾病恶化(Disease Progression);剂量效应关系, 药物(Dose-Response Relationship, Drug);男(雄)性(Male);小鼠, 转基因(Mice, Transgenic);运动神经元(Motor Neurons);神经保护药(Neuroprotective Agents);磷酸肌醇3-激酶类(Phosphatidylinositol 3-Kinases);磷酰化(Phosphorylation);蛋白激酶抑制剂(Protein Kinase Inhibitors);原癌基因蛋白质c-akt(Proto-Oncogene Proteins c-akt);超氧化物歧化酶(Superoxide Dismutase);存活率(Survival Rate);rho相关激酶类(rho-Associated Kinases)
DOI
10.1111/bph.12277
PMID
23763343
发布时间
2022-11-15
- 浏览26
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文